One Device. Revolutionary Sensitivity.
Designed to maximize target pathogen recovery from complex samples like blood, stool and urine.
Cubit enables providers to screen, diagnose and test their patients in a single visit.
Designed to maximize target pathogen recovery from complex samples like blood, stool and urine.
A simple unified workflow for immunoassay and molecular testing.
Cubit is an integrated immunoassay and molecular benchtop analyzer designed for doctor’s offices and pharmacies, eliminating the need for multiple platforms and complex testing workflows. The Cubit platform utilizes a proprietary purification methodology and low-cost microfluidic solutions to deliver actionable results exactly when and where they are needed.
True lab-quality sensitivity even from the most challenging clinical samples. Low invalid rates and minimal system downtime.
One workflow to address all immunoassay and molecular healthcare testing needs.
Test up to 8 targets per run for comprehensive syndromic testing. Perform both immunoassays and molecular testing on the same platform.
Rapid and accurate results in 15 minutes or less.
Less than 2 minutes of hands-on time with error-proof steps.
Achieving uncompromising sensitivity with low-cost targets for testing.
From concept to real-world impact.
Awarded $1.8M from RADX for Covid/Flu test & platform feasibility.
Successfully completed independent clinical evaluation study at Emory University.
We are pleased to receive funding from and collaborate with world-renowned organizations and innovators.
Learn more about our mission-driven ethos and the science behind our cutting-edge platform
Sponsored Research
Cubit is proud to work with select Universities to sponsor technology development and research projects. As part of this research, Cubit provides support for indirect costs up to a maximum rate of 20% of the total direct costs of the project. This maximum rate applies uniformly across all sponsored research projects.